EUVIMEDEUVIMED entdecken
Übersichtsarbeit

iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine

Kelvin K Hui iD, Shinya Yamanaka

BioEssays · 2024

DOI: 10.1002/bies.202400072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioEssays, 2024. Verfasst von Kelvin K Hui und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Regenerative Medicine, Induced Pluripotent Stem Cells, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This year marks the tenth anniversary of the world's first transplantation of tissue generated from induced pluripotent stem cells (iPSCs). There is now a growing number of clinical trials worldwide examining the efficacy and safety of autologous and allogeneic iPSC‐derived products for treating various pathologic conditions. As we patiently wait for the results from these and future clinical trials, it is imperative to strategize for the next generation of iPSC‐based therapies. This review examines the lessons learned from the development of another advanced cell therapy, chimeric antigen receptor (CAR) T cells, and the possibility of incorporating various new bioengineering technologies in development, from RNA engineering to tissue fabrication, to apply iPSCs not only as a means to achieve personalized medicine but also as designer medical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicineInduced Pluripotent Stem CellsCell- and Tissue-Based TherapyHumansAnimalsPrecision MedicineReceptors, Chimeric AntigenTissue Engineering

Stichwörter der Autor:innen

bioengineeringcell therapyclinical trialsiPS cellsregenerative medicinetransplantation

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • CiRA Foundation, Kyoto, Japan.
  • Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA.

ORCID-Profile: Kelvin K Hui

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Hui, K. K., & Yamanaka, S. (2024). iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine. BioEssays. https://doi.org/10.1002/bies.202400072

Vancouver

Hui KK, Yamanaka S. iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine. BioEssays. 2024. doi:10.1002/bies.202400072

BibTeX
@article{Hui2024,
  author = {Hui, Kelvin K and Yamanaka, Shinya},
  title = {iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine},
  journal = {BioEssays},
  year = {2024},
  doi = {10.1002/bies.202400072}
}
Kostenlos starten →